FC for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Open Access

Publisher Website

17 July 2019

journal article
Published by Biomedical Research Network, LLC in Biomedical Journal of Scientific & Technical Research

Vol. 19 (4), 14495-14496
https://doi.org/10.26717/bjstr.2019.19.003344

Abstract

Despite overall improvements, relapsed/refractory diffuse large B-cell lymphoma (DLBCL)remains a major cause of morbidity

Keywords